Copyright Reports & Markets. All rights reserved.

Global Human Milk Oligosaccharides in Infant Formula Market Research Report 2021

Request for Sample of this report
Buy now

1 Human Milk Oligosaccharides in Infant Formula Market Overview

  • 1.1 Product Overview and Scope of Human Milk Oligosaccharides in Infant Formula
  • 1.2 Human Milk Oligosaccharides in Infant Formula Segment by Type
    • 1.2.1 Global Human Milk Oligosaccharides in Infant Formula Market Size Growth Rate Analysis by Type 2021 VS 2027
    • 1.2.2 2’FL
    • 1.2.3 3’FL
    • 1.2.4 3’SL
    • 1.2.5 6’SL
  • 1.3 Human Milk Oligosaccharides in Infant Formula Segment by Application
    • 1.3.1 Global Human Milk Oligosaccharides in Infant Formula Consumption Comparison by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Infant Formula
    • 1.3.3 Functional Food & Beverages
    • 1.3.4 Food/Medical Supplements
    • 1.3.5 Other
  • 1.4 Global Market Growth Prospects
    • 1.4.1 Global Human Milk Oligosaccharides in Infant Formula Revenue Estimates and Forecasts (2016-2027)
    • 1.4.2 Global Human Milk Oligosaccharides in Infant Formula Production Capacity Estimates and Forecasts (2016-2027)
    • 1.4.3 Global Human Milk Oligosaccharides in Infant Formula Production Estimates and Forecasts (2016-2027)
  • 1.5 Global Human Milk Oligosaccharides in Infant Formula Market by Region
    • 1.5.1 Global Human Milk Oligosaccharides in Infant Formula Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
    • 1.5.2 North America Human Milk Oligosaccharides in Infant Formula Estimates and Forecasts (2016-2027)
    • 1.5.3 Europe Human Milk Oligosaccharides in Infant Formula Estimates and Forecasts (2016-2027)
    • 1.5.5 China Human Milk Oligosaccharides in Infant Formula Estimates and Forecasts (2016-2027)
    • 1.5.5 Japan Human Milk Oligosaccharides in Infant Formula Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers

  • 2.1 Global Human Milk Oligosaccharides in Infant Formula Production Capacity Market Share by Manufacturers (2016-2021)
  • 2.2 Global Human Milk Oligosaccharides in Infant Formula Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Human Milk Oligosaccharides in Infant Formula Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.4 Global Human Milk Oligosaccharides in Infant Formula Average Price by Manufacturers (2016-2021)
  • 2.5 Manufacturers Human Milk Oligosaccharides in Infant Formula Production Sites, Area Served, Product Types
  • 2.6 Human Milk Oligosaccharides in Infant Formula Market Competitive Situation and Trends
    • 2.6.1 Human Milk Oligosaccharides in Infant Formula Market Concentration Rate
    • 2.6.2 Global 5 and 10 Largest Human Milk Oligosaccharides in Infant Formula Players Market Share by Revenue
    • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

  • 3.1 Global Production Capacity of Human Milk Oligosaccharides in Infant Formula Market Share by Region (2016-2021)
  • 3.2 Global Human Milk Oligosaccharides in Infant Formula Revenue Market Share by Region (2016-2021)
  • 3.3 Global Human Milk Oligosaccharides in Infant Formula Production, Revenue, Price and Gross Margin (2016-2021)
  • 3.4 North America Human Milk Oligosaccharides in Infant Formula Production
    • 3.4.1 North America Human Milk Oligosaccharides in Infant Formula Production Growth Rate (2016-2021)
    • 3.4.2 North America Human Milk Oligosaccharides in Infant Formula Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.5 Europe Human Milk Oligosaccharides in Infant Formula Production
    • 3.5.1 Europe Human Milk Oligosaccharides in Infant Formula Production Growth Rate (2016-2021)
    • 3.5.2 Europe Human Milk Oligosaccharides in Infant Formula Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.6 China Human Milk Oligosaccharides in Infant Formula Production
    • 3.6.1 China Human Milk Oligosaccharides in Infant Formula Production Growth Rate (2016-2021)
    • 3.6.2 China Human Milk Oligosaccharides in Infant Formula Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.7 Japan Human Milk Oligosaccharides in Infant Formula Production
    • 3.7.1 Japan Human Milk Oligosaccharides in Infant Formula Production Growth Rate (2016-2021)
    • 3.7.2 Japan Human Milk Oligosaccharides in Infant Formula Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Human Milk Oligosaccharides in Infant Formula Consumption by Region

  • 4.1 Global Human Milk Oligosaccharides in Infant Formula Consumption by Region
    • 4.1.1 Global Human Milk Oligosaccharides in Infant Formula Consumption by Region
    • 4.1.2 Global Human Milk Oligosaccharides in Infant Formula Consumption Market Share by Region
  • 4.2 North America
    • 4.2.1 North America Human Milk Oligosaccharides in Infant Formula Consumption by Country
    • 4.2.2 U.S.
    • 4.2.3 Canada
  • 4.3 Europe
    • 4.3.1 Europe Human Milk Oligosaccharides in Infant Formula Consumption by Country
    • 4.3.2 Germany
    • 4.3.3 France
    • 4.3.4 U.K.
    • 4.3.5 Italy
    • 4.3.6 Russia
  • 4.4 Asia Pacific
    • 4.4.1 Asia Pacific Human Milk Oligosaccharides in Infant Formula Consumption by Region
    • 4.4.2 China
    • 4.4.3 Japan
    • 4.4.4 South Korea
    • 4.4.5 Taiwan
    • 4.4.6 Southeast Asia
    • 4.4.7 India
    • 4.4.8 Australia
  • 4.5 Latin America
    • 4.5.1 Latin America Human Milk Oligosaccharides in Infant Formula Consumption by Country
    • 4.5.2 Mexico
    • 4.5.3 Brazil

5 Production, Revenue, Price Trend by Type

  • 5.1 Global Human Milk Oligosaccharides in Infant Formula Production Market Share by Type (2016-2021)
  • 5.2 Global Human Milk Oligosaccharides in Infant Formula Revenue Market Share by Type (2016-2021)
  • 5.3 Global Human Milk Oligosaccharides in Infant Formula Price by Type (2016-2021)

6 Consumption Analysis by Application

  • 6.1 Global Human Milk Oligosaccharides in Infant Formula Consumption Market Share by Application (2016-2021)
  • 6.2 Global Human Milk Oligosaccharides in Infant Formula Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled

  • 7.1 Abbott
    • 7.1.1 Abbott Human Milk Oligosaccharides in Infant Formula Corporation Information
    • 7.1.2 Abbott Human Milk Oligosaccharides in Infant Formula Product Portfolio
    • 7.1.3 Abbott Human Milk Oligosaccharides in Infant Formula Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.1.4 Abbott Main Business and Markets Served
    • 7.1.5 Abbott Recent Developments/Updates
  • 7.2 BASF
    • 7.2.1 BASF Human Milk Oligosaccharides in Infant Formula Corporation Information
    • 7.2.2 BASF Human Milk Oligosaccharides in Infant Formula Product Portfolio
    • 7.2.3 BASF Human Milk Oligosaccharides in Infant Formula Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.2.4 BASF Main Business and Markets Served
    • 7.2.5 BASF Recent Developments/Updates
  • 7.3 Dextra Laboratories
    • 7.3.1 Dextra Laboratories Human Milk Oligosaccharides in Infant Formula Corporation Information
    • 7.3.2 Dextra Laboratories Human Milk Oligosaccharides in Infant Formula Product Portfolio
    • 7.3.3 Dextra Laboratories Human Milk Oligosaccharides in Infant Formula Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.3.4 Dextra Laboratories Main Business and Markets Served
    • 7.3.5 Dextra Laboratories Recent Developments/Updates
  • 7.4 DuPont
    • 7.4.1 DuPont Human Milk Oligosaccharides in Infant Formula Corporation Information
    • 7.4.2 DuPont Human Milk Oligosaccharides in Infant Formula Product Portfolio
    • 7.4.3 DuPont Human Milk Oligosaccharides in Infant Formula Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.4.4 DuPont Main Business and Markets Served
    • 7.4.5 DuPont Recent Developments/Updates
  • 7.5 Elicityl
    • 7.5.1 Elicityl Human Milk Oligosaccharides in Infant Formula Corporation Information
    • 7.5.2 Elicityl Human Milk Oligosaccharides in Infant Formula Product Portfolio
    • 7.5.3 Elicityl Human Milk Oligosaccharides in Infant Formula Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.5.4 Elicityl Main Business and Markets Served
    • 7.5.5 Elicityl Recent Developments/Updates
  • 7.6 Glycom
    • 7.6.1 Glycom Human Milk Oligosaccharides in Infant Formula Corporation Information
    • 7.6.2 Glycom Human Milk Oligosaccharides in Infant Formula Product Portfolio
    • 7.6.3 Glycom Human Milk Oligosaccharides in Infant Formula Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.6.4 Glycom Main Business and Markets Served
    • 7.6.5 Glycom Recent Developments/Updates
  • 7.7 Glycosyn
    • 7.7.1 Glycosyn Human Milk Oligosaccharides in Infant Formula Corporation Information
    • 7.7.2 Glycosyn Human Milk Oligosaccharides in Infant Formula Product Portfolio
    • 7.7.3 Glycosyn Human Milk Oligosaccharides in Infant Formula Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.7.4 Glycosyn Main Business and Markets Served
    • 7.7.5 Glycosyn Recent Developments/Updates
  • 7.8 Inbiose
    • 7.8.1 Inbiose Human Milk Oligosaccharides in Infant Formula Corporation Information
    • 7.8.2 Inbiose Human Milk Oligosaccharides in Infant Formula Product Portfolio
    • 7.8.3 Inbiose Human Milk Oligosaccharides in Infant Formula Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.8.4 Inbiose Main Business and Markets Served
    • 7.7.5 Inbiose Recent Developments/Updates
  • 7.9 Jennewein Biotechnologie
    • 7.9.1 Jennewein Biotechnologie Human Milk Oligosaccharides in Infant Formula Corporation Information
    • 7.9.2 Jennewein Biotechnologie Human Milk Oligosaccharides in Infant Formula Product Portfolio
    • 7.9.3 Jennewein Biotechnologie Human Milk Oligosaccharides in Infant Formula Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.9.4 Jennewein Biotechnologie Main Business and Markets Served
    • 7.9.5 Jennewein Biotechnologie Recent Developments/Updates
  • 7.10 Nestle Health Science
    • 7.10.1 Nestle Health Science Human Milk Oligosaccharides in Infant Formula Corporation Information
    • 7.10.2 Nestle Health Science Human Milk Oligosaccharides in Infant Formula Product Portfolio
    • 7.10.3 Nestle Health Science Human Milk Oligosaccharides in Infant Formula Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.10.4 Nestle Health Science Main Business and Markets Served
    • 7.10.5 Nestle Health Science Recent Developments/Updates
  • 7.11 Zuchem
    • 7.11.1 Zuchem Human Milk Oligosaccharides in Infant Formula Corporation Information
    • 7.11.2 Zuchem Human Milk Oligosaccharides in Infant Formula Product Portfolio
    • 7.11.3 Zuchem Human Milk Oligosaccharides in Infant Formula Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.11.4 Zuchem Main Business and Markets Served
    • 7.11.5 Zuchem Recent Developments/Updates

8 Human Milk Oligosaccharides in Infant Formula Manufacturing Cost Analysis

  • 8.1 Human Milk Oligosaccharides in Infant Formula Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Key Raw Materials Price Trend
    • 8.1.3 Key Suppliers of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.3 Manufacturing Process Analysis of Human Milk Oligosaccharides in Infant Formula
  • 8.4 Human Milk Oligosaccharides in Infant Formula Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

  • 9.1 Marketing Channel
  • 9.2 Human Milk Oligosaccharides in Infant Formula Distributors List
  • 9.3 Human Milk Oligosaccharides in Infant Formula Customers

10 Market Dynamics

  • 10.1 Human Milk Oligosaccharides in Infant Formula Industry Trends
  • 10.2 Human Milk Oligosaccharides in Infant Formula Growth Drivers
  • 10.3 Human Milk Oligosaccharides in Infant Formula Market Challenges
  • 10.4 Human Milk Oligosaccharides in Infant Formula Market Restraints

11 Production and Supply Forecast

  • 11.1 Global Forecasted Production of Human Milk Oligosaccharides in Infant Formula by Region (2022-2027)
  • 11.2 North America Human Milk Oligosaccharides in Infant Formula Production, Revenue Forecast (2022-2027)
  • 11.3 Europe Human Milk Oligosaccharides in Infant Formula Production, Revenue Forecast (2022-2027)
  • 11.4 China Human Milk Oligosaccharides in Infant Formula Production, Revenue Forecast (2022-2027)
  • 11.5 Japan Human Milk Oligosaccharides in Infant Formula Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast

  • 12.1 Global Forecasted Demand Analysis of Human Milk Oligosaccharides in Infant Formula
  • 12.2 North America Forecasted Consumption of Human Milk Oligosaccharides in Infant Formula by Country
  • 12.3 Europe Market Forecasted Consumption of Human Milk Oligosaccharides in Infant Formula by Country
  • 12.4 Asia Pacific Market Forecasted Consumption of Human Milk Oligosaccharides in Infant Formula by Region
  • 12.5 Latin America Forecasted Consumption of Human Milk Oligosaccharides in Infant Formula by Country

13 Forecast by Type and by Application (2022-2027)

  • 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
    • 13.1.1 Global Forecasted Production of Human Milk Oligosaccharides in Infant Formula by Type (2022-2027)
    • 13.1.2 Global Forecasted Revenue of Human Milk Oligosaccharides in Infant Formula by Type (2022-2027)
    • 13.1.3 Global Forecasted Price of Human Milk Oligosaccharides in Infant Formula by Type (2022-2027)
  • 13.2 Global Forecasted Consumption of Human Milk Oligosaccharides in Infant Formula by Application (2022-2027)

14 Research Finding and Conclusion

    15 Methodology and Data Source

    • 15.1 Methodology/Research Approach
      • 15.1.1 Research Programs/Design
      • 15.1.2 Market Size Estimation
      • 15.1.3 Market Breakdown and Data Triangulation
    • 15.2 Data Source
      • 15.2.1 Secondary Sources
      • 15.2.2 Primary Sources
    • 15.3 Author List

    The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    2’FL
    3’FL
    3’SL
    6’SL

    Segment by Application
    Infant Formula
    Functional Food & Beverages
    Food/Medical Supplements
    Other

    By Company
    Abbott
    BASF
    Dextra Laboratories
    DuPont
    Elicityl
    Glycom
    Glycosyn
    Inbiose
    Jennewein Biotechnologie
    Nestle Health Science
    Zuchem

    Production by Region
    North America
    Europe
    China
    Japan

    Consumption by Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    Buy now